Adherium Share Purchase Plan (SPP) and Shortfall Offers Prospectus
As announced on 16 September 2022, the Company received subscription commitments from new and existing institutional and sophisticated investors for $13.5 million of new shares. The Company also wishes to offer its existing shareholders the opportunity under the SPP to participate at the same offer price as applicable under the previous placements and to also receive one New Option for every two New Shares issued under the Offers.
The SPP Offer gives Eligible Shareholders the opportunity to subscribe for up to $20,000 worth of new fully paid ordinary shares in the Company (New Shares) at an issue price of $0.005 per New Share, in parcel sizes of $5,000, $10,000, $15,000 or $20,000, subject to the Company's allocation policy, without incurring any brokerage or transaction costs. In addition, the SPP Offer includes the issue to the subscribers of one New Option for every two New Shares subscribed and issued under the SPP Offer.
Eligible Shareholders and other investors may also apply under the Shortfall Offer to subscribe for New Shares and New Options not applied for and allotted under the SPP Offer.
If you are accessing the electronic version of the Prospectus below for the purpose of making an investment in the Company under the SPP Offer, you must be an Australian or New Zealand resident and must only access this Prospectus from within Australia or New Zealand. If you are accessing the electronic version of this Prospectus for the purpose of making an investment in the Company under the Shortfall Offer, you must be an Eligible Shareholder or a resident of an Exempt Jurisdiction. For clarity, the Prospectus below is not for publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the US and the District of Columbia). The Prospectus is not an offer of securities for sale into the United States or to, or for the account or benefit of, US Persons. The securities referred to therein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, US Persons. No public offering of securities is being made in the United States.